Autres langues CalciMedica, Inc. OTC Markets

Actions

CALC

US38942Q2021

Marché Fermé - OTC Markets Autres places de cotation 22:30:01 16/07/2024			Varia. 5j.	Varia. 1 janv.
4,88 ^USD	+1,46 %		+13,18 %	+68,18 %

09/07	CalciMedica annonce que la première personne a reçu une dose dans le cadre de l'essai de phase 2 d'Auxora pour le traitement des lésions rénales aiguës	MT
09/07	CalciMedica Inc. annonce le recrutement du premier patient dans l'essai de phase 2 KOURAGE d'Auxora ? pour le traitement des lésions rénales aiguës sévères	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora in Severe Acute Kidney Injury	10/07
CalciMedica Says First Person Dosed in Phase 2 Trial of Auxora to Treat Acute Kidney Injury	09/07
CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)	09/07
CalciMedica Inc. Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora? in Severe Acute Kidney Injury	09/07
CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences	08/07
CalciMedica Set to Join Russell Microcap Index	02/07
CalciMedica Set to Join Russell Microcap® Index	01/07
CalciMedica, Inc.(NasdaqCM:CALC) added to Russell Microcap Growth Index	01/07
CalciMedica, Inc.(NasdaqCM:CALC) added to Russell 3000E Index	01/07
CalciMedica, Inc.(NasdaqCM:CALC) added to Russell Microcap Index	01/07
CalciMedica, Inc.(NasdaqCM:CALC) added to Russell 3000E Growth Index	01/07
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis	28/06
CalciMedica : CARPO Trial Topline Results presentation	27/06
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)	27/06
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora? in Acute Pancreatitis	27/06
CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)	26/06
CalciMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates	13/05
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora in Acute Pancreatitis	25/04
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis	24/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues CalciMedica, Inc. OTC Markets

Actions

CALC

US38942Q2021

Autres langues

Filtres